INNA BAIR: Open Payments
NPI 1063076412 · CENTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 90 payments from 15 companies in 2025. Trend: 2023 $1,145 · 2024 $1,686 · 2025 $1,594
Food & beverage: $1,594
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $490 |
| Amgen Inc. | 10 | $212 |
| Lilly USA, LLC | 11 | $163 |
| Janssen Biotech, Inc. | 8 | $160 |
| Novo Nordisk Inc | 8 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $101 |
| UCB, Inc. | 5 | $100 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $34 |
Products named: VRAYLAR, TREMFYA, MOUNJARO, EVENITY, Kerendia, Bimzelx, Ozempic, UBRELVY.
Industry payments across OH — which companies pay providers there.
